Transcutaneous immunization with CD40 ligation boosts cytotoxic T lymphocyte mediated antitumor immunity independent of CD4 helper cells in mice-Reference-Cited by-同舟云学术

Transcutaneous immunization with CD40 ligation boosts cytotoxic T lymphocyte mediated antitumor immunity independent of CD4 helper cells in mice

Published:2019-08-19 Issue:11 Volume:49 Page:2083-2094
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur. J. Immunol.

Author:

Bialojan Ariane¹,Sohl Julian¹,Rausch Johanna¹,Aranda Lopez Pamela¹,Denny Mark²,Langguth Peter²,Hartmann Ann‐Kathrin¹³,Yagita Hideo⁴,Probst Hans Christian³,Schild Hansjörg³,Radsak Markus P.¹^ORCID

Affiliation:

1. Third Department of Medicine ‐ Hematology, Oncology, Pneumology University Medical Center of the Johannes Gutenberg‐University Mainz Germany

2. Biopharmaceutics and Pharmaceutical Technology Johannes Gutenberg‐University Mainz Germany

3. Institute of Immunology University Medical Center of the Johannes Gutenberg‐University Mainz Germany

4. Department of Immunology Juntendo University Tokyo Japan

Funder

Deutsche Forschungsgemeinschaft

Johannes Gutenberg-Universität Mainz

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/eji.201848039

Reference43 articles.

1. Cancer immunotherapy beyond immune checkpoint inhibitors;Marin‐Acevedo J. A.;J Hematol,2018

2. Nanoparticulate mediated transcutaneous immunization: Myth or reality

3. Skin immunization made possible by cholera toxin

4. Vaccine allergy and pseudo‐allergy;Ponvert C.;Eur. J. Dermatol,2003

5. Cutting Edge: Priming of CTL by Transcutaneous Peptide Immunization with Imiquimod

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The application of nanoparticle-based delivery systems in vaccine development;Advanced Vaccination Technologies for Infectious and Chronic Diseases;2024

2. Leveraging Lymphatic System Targeting in Systemic Lupus Erythematosus for Improved Clinical Outcomes;Pharmacological Reviews;2023-12-13

3. Biomaterial-based delivery platforms for transdermal immunotherapy;Biomedicine & Pharmacotherapy;2023-09

4. Dithranol as novel co-adjuvant for non-invasive dermal vaccination;npj Vaccines;2022-09-24

5. Nanovaccine for transdermal delivery system;Journal of Drug Delivery Science and Technology;2022-01